Endo International PLC (NASDAQ:ENDP) (TSE:ENL) – Stock analysts at SunTrust Banks issued their Q1 2019 EPS estimates for Endo International in a research report issued on Tuesday, March 19th, Zacks Investment Research reports. SunTrust Banks analyst G. Gilbert expects that the company will earn $0.39 per share for the quarter. SunTrust Banks currently has a “Buy” rating and a $13.00 price objective on the stock. SunTrust Banks also issued estimates for Endo International’s Q2 2019 earnings at $0.53 EPS, Q3 2019 earnings at $0.58 EPS, Q4 2019 earnings at $0.65 EPS, FY2019 earnings at $2.15 EPS, FY2020 earnings at $2.48 EPS, FY2021 earnings at $2.28 EPS, FY2022 earnings at $1.46 EPS and FY2023 earnings at $1.85 EPS.
Endo International (NASDAQ:ENDP) (TSE:ENL) last released its earnings results on Thursday, February 28th. The company reported $0.75 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.59 by $0.16. Endo International had a negative net margin of 35.00% and a negative return on equity of 337.13%. The business had revenue of $786.39 million during the quarter, compared to analyst estimates of $744.24 million. During the same quarter in the prior year, the firm earned $0.77 earnings per share.
Shares of Endo International stock traded up $0.01 during trading hours on Friday, reaching $7.55. 2,164,768 shares of the company’s stock were exchanged, compared to its average volume of 3,269,144. The firm has a market capitalization of $1.69 billion, a price-to-earnings ratio of 2.61 and a beta of 1.17. Endo International has a 1 year low of $5.31 and a 1 year high of $18.50.
Several hedge funds have recently bought and sold shares of the company. Tibra Equities Europe Ltd acquired a new stake in shares of Endo International in the first quarter valued at approximately $621,000. Norges Bank acquired a new stake in shares of Endo International during the fourth quarter worth $21,218,000. Nordea Investment Management AB lifted its holdings in shares of Endo International by 23.0% during the fourth quarter. Nordea Investment Management AB now owns 129,200 shares of the company’s stock worth $943,000 after purchasing an additional 24,200 shares during the period. Globeflex Capital L P lifted its holdings in shares of Endo International by 2.6% during the fourth quarter. Globeflex Capital L P now owns 214,135 shares of the company’s stock worth $1,563,000 after purchasing an additional 5,391 shares during the period. Finally, Municipal Employees Retirement System of Michigan acquired a new stake in shares of Endo International during the fourth quarter worth $421,000. 95.69% of the stock is owned by institutional investors and hedge funds.
Endo International Company Profile
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.
Featured Story: How the Consumer Price Index (CPI) is calculated?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.